Vivid Explorer/Vivid Advanced/Vivid Focus— 510(k) K261313
Substantially EquivalentGE Medical Systems Ultrasound and Primary Care Diagnostics
FDA 510(k) clearance K261313 for Vivid Explorer/Vivid Advanced/Vivid Focus, Substantially Equivalent on 2026-09-02. Applicant: GE Medical Systems Ultrasound and Primary Care Diagnostics. Device class: 2.
Summary
GE Medical Systems Ultrasound and Primary Care Diagnostics filed Vivid Explorer/Vivid Advanced/Vivid Focus under product code IYN (System, Imaging, Pulsed Doppler, Ultrasonic). The record doesn't say how the three named systems differ.
Class II, 21 CFR 892.1550. Radiology is both the classification panel and the review panel. It was a Traditional 510(k), decided Substantially Equivalent.
GE filed from Waukesha, Wisconsin. The decision came 134 calendar days after FDA received it (April 21 to September 2, 2026).
Clearance details
- Applicant
- GE Medical Systems Ultrasound and Primary Care Diagnostics
- Product code
- Product code IYN
- Device class
- Class 2
- Regulation
- 21 CFR 892.1550
- Advisory panel
- Radiology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Waukesha, WI, US
Recent devices under product code IYN
view all- K261585 — Diagnostic Ultrasound System (Nuewa A20W) +10 more
- K261617 — Diagnostic Ultrasound System (11+ models)
- K263150 — V10 Diagnostic Ultrasound System +10 more
- K261933 — Voluson Expert 18; Voluson Expert 20; Voluson Expert 22
- K262548 — EPIQ Inspira Series Diagnostic Ultrasound System; Affiniti Series Diagnostic Ultrasound System
More clearances from GE Medical Systems Ultrasound and Primary Care Diagnostics
view allAdverse events under product code IYN
product code IYN- Death
- 25
- Injury
- 163
- Malfunction
- 1,538
- Other
- 4
- Total
- 1,730
Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →
Data sourced from openFDA. This site is unofficial and independent of the FDA.